Trial intelligence / Profile preview

Ultrasound Therapy in Knee Osteoarthritis

NCT07738692Completed

Sponsor
Horus Pharma
Start
Jan 2026
Primary completion
Apr 2026
Countries
1
01

Overview

Randomised trial of metformin 1% gel in knee osteoarthritis (OA) (3 arms), sponsored by Horus Pharma. Primary endpoints: Visual Analog Scale at 12 weeks, Western Ontario and McMaster Universities Arthritis Index at 12 weeks and 1 more. Started Jan 2026; status: completed.

02

Drugs

metformin 1% gel
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT07738692.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07738692.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call